Use of MEOPA (Equimolar Mixture of Nitrogen Protoxide and Oxygen) for Elderly With Dementia
Not Applicable
Completed
- Conditions
- Dementia
- Interventions
- Drug: MEOPA
- Registration Number
- NCT00822224
- Lead Sponsor
- Centre Hospitalier Universitaire de Nice
- Brief Summary
Acute pain is frequent in elderly especially in geriatrics acute care units where painful procedures are often occurring.
MEOPA represents an alternative to opioïd therapy to prevent procedural pain during the treatment of pressure ulcers.
In this study, cognitive impairment and dementia do not limit the use of MEOPA. The new approach in the management of acute procedural pain provides effective and safe analgesia in frail old patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- dementia (Folstein scoring between 0 and 25)
- older than 75
- health necessitating of painful care for example eschar care
Exclusion Criteria
- bullous emphysema
- pneumothorax
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description 1 MEOPA Use of MEOPA during the painful care
- Primary Outcome Measures
Name Time Method feasibility of use of MEOPA as tolerance to mask, MEOPA inhalation one time, at the first care with MEOPA
- Secondary Outcome Measures
Name Time Method satisfaction rate of patient one time, at the first care with MEOPA
Trial Locations
- Locations (1)
Gerontology department, Nice University Hospital
🇫🇷Nice, France